2. GPCR/G Protein
  3. Free Fatty Acid Receptor
  4. AH-7614

AH-7614 is a potent and selective FFA4 (GPR120) antagonist, with pIC50s of 7.1, 8.1, and 8.1 for human, mouse, and rat FFA4, respectively. AH-7614 has selectivity for FFA4 over FFA1 (pIC50<4.6). AH-7614 is able to block effects of both the polyunsaturated ω-6 fatty acid linoleic acid and the synthetic FFA4 agonist.

For research use only. We do not sell to patients.

CAS No. : 6326-06-3

Size Price Stock Quantity
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
 In-stock
Solution
10 mM * 1 mL in DMSO In-stock
Solid
5 mg In-stock
10 mg In-stock
25 mg In-stock
50 mg In-stock
100 mg In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 6 publication(s) in Google Scholar

AH-7614 Related Antibodies

Top Publications Citing Use of Products

    AH-7614 purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Jan 21:e2407942.  [Abstract]

    Quantification of the proliferation of AsPC-1 and PANC-1 cells treated for 24 h with 50 nM AH-7614 or vehicle via CCK-8 (n = 4) assays.

    AH-7614 purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Jan 21:e2407942.  [Abstract]

    Quantification of the proliferation of AsPC-1 and PANC-1 cells treated for 24 h with 50 nM AH-7614 or vehicle in colony formation (n = 3) assays.

    AH-7614 purchased from MedChemExpress. Usage Cited in: EMBO Rep. 2024 Dec;25(12):5507-5536.  [Abstract]

    To verify the efficacy of AH7614 (100 μM, pretreatment for 1 hour), protein level of GPR120 was determined in RAW264.7 cells.

    AH-7614 purchased from MedChemExpress. Usage Cited in: J Nutr Biochem. 2025 Jan:135:109772.

    Representative Oil Red O (ORO) staining and relative ORO optical density (OD) value of DMSO control, AH7614 (10 μM), 30 µM PB, or AH7614+30 µM PB-treated preadipocytes.

    AH-7614 purchased from MedChemExpress. Usage Cited in: J Nutr Biochem. 2025 Jan:135:109772.

    Representative BODIPY staining and relative quantification of preadipocytes treated with DMSO control, AH7614 (10 μM), 30 µM PB, or AH7614+30 µM PB.

    AH-7614 purchased from MedChemExpress. Usage Cited in: J Nutr Biochem. 2025 Jan:135:109772.

    Representative immunoblotting analysis and qualification of HSL, FASN, CEBPβ, PPARγ in preadipocytes treated with DMSO control, AH7614 (10 μM), 30 µM PB, or AH7614+30 µM PB.

    View All Free Fatty Acid Receptor Isoform Specific Products:

    View All Isoforms
    FFAR1 FFAR2 FFAR3 FFAR4

    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    AH-7614 is a potent and selective FFA4 (GPR120) antagonist, with pIC50s of 7.1, 8.1, and 8.1 for human, mouse, and rat FFA4, respectively. AH-7614 has selectivity for FFA4 over FFA1 (pIC50<4.6). AH-7614 is able to block effects of both the polyunsaturated ω-6 fatty acid linoleic acid and the synthetic FFA4 agonist[1][2].

    IC50 & Target

    pIC50: 7.1 (human FFA4)[1]
    In Vitro

    AH-7614 (compound 39) (0.063-1 μM) blocks intracellular Ca2+ response induced by both linoleic acid and FFAR4 agonist in FFA4 expressing U2OS cells[1].
    AH-7614 (100 μM) abolishes the enhancement in glucose-stimulated insulin secretion by GSK137647A in NCI-H716 cells[1].
    AH-7614 (0.001-10 μM; 15 min) blocks TUG-891-mediated internalization of FFA4 from the cell surface (pIC50=7.70)[2].
    AH-7614 (10 μM; 30 min) blocks agonist-induced elevation of intracellular inositol monophosphates and phosphorylation of FFA4[2].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    AH-7614 Related Antibodies
    In Vivo

    AH7614 (50 μg; intratumoral injection once every 4 d for 20 d) reduces the tumor growth in mice[3].
    AH7614 (50 μg; intratumoral injection one day prior to epirubicin injection) enhances cancer cell sensitivity to the chemotherapy and inhibits tumor progression by blocking GPR120 signaling in combination with Epirubicin[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
    Molecular Weight

    351.42

    Formula

    C20H17NO3S
    CAS No.
    Appearance

    Solid

    Color

    White to off-white

    SMILES

    O=S(C1=CC=C(C)C=C1)(NC2C3=C(OC4=C2C=CC=C4)C=CC=C3)=O
    Shipping

    Room temperature in continental US; may vary elsewhere.
    Storage
    Powder -20°C 3 years
    4°C 2 years
    In solvent -80°C 6 months
    -20°C 1 month
    Solvent & Solubility
    In Vitro: 

    DMSO : 100 mg/mL (284.56 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 2.8456 mL 14.2280 mL 28.4560 mL
    5 mM 0.5691 mL 2.8456 mL 5.6912 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    90% Corn Oil

      Solubility: ≥ 2.5 mg/mL (7.11 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    % 
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    Purity & Documentation

    Purity: 99.64%

    SDS (251 KB)

    COA (257 KB) LCMS (105 KB)

    Handling Instructions (2659 KB)
    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 2.8456 mL 14.2280 mL 28.4560 mL 71.1399 mL
    5 mM 0.5691 mL 2.8456 mL 5.6912 mL 14.2280 mL
    10 mM 0.2846 mL 1.4228 mL 2.8456 mL 7.1140 mL
    15 mM 0.1897 mL 0.9485 mL 1.8971 mL 4.7427 mL
    20 mM 0.1423 mL 0.7114 mL 1.4228 mL 3.5570 mL
    25 mM 0.1138 mL 0.5691 mL 1.1382 mL 2.8456 mL
    30 mM 0.0949 mL 0.4743 mL 0.9485 mL 2.3713 mL
    40 mM 0.0711 mL 0.3557 mL 0.7114 mL 1.7785 mL
    50 mM 0.0569 mL 0.2846 mL 0.5691 mL 1.4228 mL
    60 mM 0.0474 mL 0.2371 mL 0.4743 mL 1.1857 mL
    80 mM 0.0356 mL 0.1778 mL 0.3557 mL 0.8892 mL
    100 mM 0.0285 mL 0.1423 mL 0.2846 mL 0.7114 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.

    AH-7614 Related Classifications

    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Keywords:

    AH-76146326-06-3AH7614AH 7614Free Fatty Acid ReceptorFFARFFA4negativeallostericNAMlinoleicacidGPR120Inhibitorinhibitorinhibit

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

    		  

    Requested Quantity *

    Applicant Name *

    		 

    Salutation

    Email Address *

    		 

    Phone Number *

    Department

    		 

    Organization Name *

    City

    State

    Country or Region *

    		      

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    AH-7614
    Cat. No.:
    HY-19996
    Quantity:
    MCE Japan Authorized Agent:

    Customer Review

    Thank You for Your Feedback!

    Request for HNMR Report

    Please fill out this form to request the QC report. We will send it to your Email address shortly.

    Your information is safe with us. * Required Fields.

    Product Name

    		  

    Lot #

    Applicant Name *

    		 

    Email Address *

    Phone Number

    		 

    Department *

    Organization Name *

    		 

    Country or Region *

    Remarks

    SAFETY DATA SHEET (SDS)

    English - EN (251 KB) Français - FR (251 KB) Deutsch - DE (251 KB) Norwegian - NO (251 KB) Español - ES (251 KB) Swedish - SV (251 KB) Italian - IT (251 KB) Korean - KR (251 KB) Portuguese - PT (251 KB)

    Request for HNMR Report

    We have received your request and will respond to you as soon as possible.